CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide

CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide

Chemotherapy resistant leukemic stem cells (LSCs) are being targeted as a modern therapeutic approach to prevent disease relapse. LSCs isolated from methotrexate resistant side population (SP) of leukemic cell lines HL60 and MOLT4 exhibited high levels of CD25 and TRAIL R2/DR5 which are potential ta...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Jayaprakasam Madhumathi, Surapally Sridevi, Rama Shanker Verma
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Elsevier 2017-03-01
Ráidu:Stem Cell Research
Fáttát:
Leukemic stem cells
Immunotoxin
DR5 receptor
Drug resistance
TRAIL
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S1873506117300016

Interneahtta

http://www.sciencedirect.com/science/article/pii/S1873506117300016

Geahča maid